Share this post on:

Product Name :
Tecovirimat

Search keywords :
Tecovirimat

drugId :
null

Target Vo:
Recombinant envelope protein

Target Vo Short Name :
env

Moa_Name:
Recombinant envelope protein inhibitors

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Siga Technologies Inc

Active Company_Name :
Bioarchitech Ltd

Active Indication_Name:
Monkeypox

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ozoralizumab Epigenetic Reader Domain
EpCAM Mouse mAb custom synthesis
Wnt5a Antibody: Wnt5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Wnt5a. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related